Pharmaceutical Executive
Pharmaceutical Executive Daily: FDA Issues CRL to Elevar Therapeutics
July 13 · 2 min · 2.7 MB
0:00-2:48
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
In today's Pharmaceutical Executive Daily, a new industry analysis warns that direct-to-patient pharma platforms are scaling faster than the safety infrastructure needed to support them, FDA issues a complete response letter to Elevar Therapeutics over manufacturing deficiencies in its liver cancer combination therapy, and Insilico Medicine deepens its partnership with China Medical System Holdings in a new AI-powered drug discovery collaboration worth up to $177 million.
No links were found in this episode’s notes.